Shanghai Jmt-bio Inc.

This early-phase study tests a new drug called JMT106 in about 200 adults with advanced solid tumors (including lung and liver cancer) who have run out of standard options. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants…

This study tests a new injection called JMT202 in people with very high triglycerides, a type of fat in the blood that can raise heart risk. About 48 Chinese adults will receive either the drug or a placebo to check safety and how well it works. The goal is to see if the injectio…

This study tests a new drug called JMT108 in people with advanced melanoma that cannot be removed by surgery or has spread. The goal is to see if the drug is safe and can shrink tumors. About 188 adults who have tried other treatments or have no options left will take part. This …

This study tests a new drug called JMT108 in people with advanced cancers that have not responded to other treatments. The main goals are to check if the drug is safe and to find the best dose. About 436 adults will take part in this early-phase trial across multiple centers.

This study tests whether a new drug combination (KN026 plus HB1801 and chemo) works better than the current standard therapy (trastuzumab, pertuzumab, and chemo) to prevent breast cancer from coming back after surgery. About 1800 adults with HER2-positive breast cancer that has s…

This study tests a new drug called JMT203 in people with lung or pancreatic cancer who are losing weight and muscle (cancer cachexia). The goal is to see if the drug is safe and can help patients gain or maintain weight. About 307 adults will take part across two phases, starting…

This early-stage study tests a single dose of JMT206 injection in healthy volunteers aged 18 to 60. The main goal is to check if the drug is safe and how the body processes it. No treatment benefit is expected; the study gathers important safety information for future research.